Reata Pharmaceuticals Inc - TX Dallas, Irving 75063

Reata Pharmaceuticals Inc entered the industry of Research and Development Laboratories in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code , which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code and described it as a Research and Development Laboratories. The business provides service to the B2B market.

To acquire more information, please contact Paul Wade by calling (972) 573-0570 during business hours. You can also write to the business’ Single Location at 2801 Gateway Drive # 150, Irving, Texas TX 75063. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Reata Pharmaceuticals Inc
Representative: Paul Wade
Place of Business: 2801 Gateway Drive # 150, Irving, TX 75063
Contact Number: (972) 573-0570
Type of Service: Research and Development Laboratories
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2002
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Reata Pharmaceuticals Inc is a company operating from Dallas, Texas providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2002 and registered with the SIC code as Research and Development Laboratories, and with the NAICS code as Research and Development Laboratories.

With a current employee count of 1 to 4, Reata Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Paul Wade at (972) 573-0570 for related queries, or to locate its Single Location using the coordinates 32.8937,-96.98573.

The Single Location can also be found at the street address 2801 Gateway Drive # 150 in Irving, Texas 75063 and can be engaged online through the company website at , the company Twitter , and Facebook page .